Evidence map›Paper›PMID 40079326›Full record

SynthesisJournal of the American Heart Association2025

P2Y

Juan F Iglesias, Benjamin Assouline, Quentin Chatelain, Yazan Musayeb, Sophie Degrauwe, Marco Roffi

Abstract readSystematic ReviewMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Personalized Antithrombotic Therapy After Percutaneous Coronary Intervention: A Systematic Review of Risk-Stratified Approaches.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Juan F IglesiasDepartment of Cardiology Geneva University Hospitals Geneva Switzerland.ORCID 0000-0002-1669-6036
Benjamin AssoulineIntensive Care Unit Geneva University Hospitals Geneva Switzerland.
Quentin ChatelainDepartment of Cardiology Geneva University Hospitals Geneva Switzerland.
Yazan MusayebDepartment of Cardiology Geneva University Hospitals Geneva Switzerland.
Sophie DegrauweDepartment of Cardiology Geneva University Hospitals Geneva Switzerland.ORCID 0000-0002-2484-0835
Marco RoffiDepartment of Cardiology Geneva University Hospitals Geneva Switzerland.ORCID 0000-0002-3051-0170

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundP2Y METHODS AND

resultsPubMed, Embase, and Cochrane Central Register of Controlled Trials were searched for randomized controlled trials comparing oral P2Y

conclusionsCompared with 12-month DAPT, P2Y REGISTRATION: URL: https://www.crd.york.ac.uk/prospero/; Unique identifier: CRD42023239341.

Indexed as

Acute Coronary SyndromeDrug-Eluting StentsDual Anti-Platelet TherapyPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsChronic DiseaseHemorrhageHumansRandomized Controlled Trials as TopicTreatment OutcomePlatelet Aggregation InhibitorsPurinergic P2Y Receptor Antagonistsacute coronary syndromedrug‐eluting stentP2Y12 receptor inhibitorpercutaneous coronary intervention

Identifiers

PMID40079326
PMCPMC12132633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.